Bupivacaine implant

N/A

Report date: 2025/03/05 20:00:52

Base Information

Drug NameBupivacaine implant
Drug Alias NameATX-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel alpha subunit blockers
TargetsSodium channel alpha subunit
Therapy Area/IndicationsPain, Postoperative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesAustralia +[4
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAllay Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAllay Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsPain, Postoperative
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A